Drug Research is intended for scientists, clinicians, and professionals involved in drug discovery, drug development, translational medicine, pharmacology, toxicology, and the evaluation of therapeutic compounds. It serves researchers working with both novel and established drug molecules, as well as those engaged in clinical trials, industrial investigations, and the quantitative assessment of drug efficacy and safety.

Drug Research (formerly Arzneimittelforschung) is an international peer‑reviewed journal with expedited processing times presenting the very latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. The journal also addresses the mathematical and statistical methods for evaluating results from industrial investigations and clinical trials.

Drug Research publishes the following article types, Original Article, Review, Short Communication, Commentary, Letter, Controversy, and Opinion Paper.

Drug Research publishes 12 issues per annum.

The journal presents research related to novel and established drug molecules and the evaluation of new drug development. Its scope includes translational medicine and the application of biological discoveries to clinical drug development, as well as analytics applied to clinical trials, chemistry and biochemistry, clinical and experimental pharmacology, drug interactions, efficacy testing, pharmacodynamics, pharmacokinetics, teratology, and toxicology. It also encompasses the mathematical and statistical methods used to evaluate results from industrial investigations and clinical trials.